Simcere Pharmaceutical Group Limited (HKG:2096)

HKG:2096 Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 9, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	34,275	17,653	17,611	30,914	23,628	23,347
Market Cap Growth	89.31%	0.24%	-43.03%	30.83%	1.20%	-
Enterprise Value	32,689	15,639	16,205	29,371	23,209	26,834
Last Close Price	13.85	6.98	6.42	10.84	8.23	8.09
PE Ratio	35.31	22.63	22.37	29.38	12.77	29.36
Forward PE	25.37	14.35	12.11	29.04	26.63	18.00
PS Ratio	4.40	2.50	2.42	4.32	3.85	4.36
PB Ratio	4.32	2.35	2.21	3.83	2.98	3.68
P/TBV Ratio	5.49	2.81	2.51	4.16	3.10	3.89
P/FCF Ratio	-	16.04	-	27.04	-	-
P/OCF Ratio	-	11.93	105.83	20.19	-	203.24
PEG Ratio	-	1.12	1.12	1.12	1.12	-
EV/Sales Ratio	4.20	2.22	2.23	4.11	3.78	5.01
EV/EBITDA Ratio	19.98	10.83	15.90	31.86	44.76	29.79
EV/EBIT Ratio	23.56	12.97	20.69	42.85	81.03	37.66
EV/FCF Ratio	-	14.21	-	25.69	-	-
Debt / Equity Ratio	0.17	0.17	0.20	0.21	0.25	0.62
Debt / EBITDA Ratio	0.82	0.84	1.43	1.72	3.50	4.10
Debt / FCF Ratio	-	1.17	-	1.49	-	-
Asset Turnover	0.58	0.59	0.61	0.60	0.47	0.51
Inventory Turnover	2.04	1.80	2.84	4.01	3.59	2.94
Quick Ratio	1.51	1.73	1.76	1.69	1.51	1.48
Current Ratio	1.73	2.00	2.10	1.84	1.63	1.85
Return on Equity (ROE)	12.45%	10.26%	9.94%	13.62%	25.41%	19.49%
Return on Assets (ROA)	6.50%	6.33%	4.11%	3.62%	1.38%	4.23%
Return on Capital (ROIC)	9.55%	8.37%	5.13%	4.52%	1.74%	5.74%
Return on Capital Employed (ROCE)	13.90%	12.90%	8.70%	7.80%	3.30%	8.10%
Earnings Yield	2.81%	4.42%	4.47%	3.40%	7.83%	3.41%
FCF Yield	-	6.23%	-2.08%	3.70%	-2.14%	-1.30%
Dividend Yield	1.26%	2.44%	2.74%	1.67%	2.24%	2.20%
Payout Ratio	-	54.76%	58.65%	42.04%	25.96%	-
Buyback Yield / Dilution	4.18%	3.40%	0.45%	-0.34%	-9.14%	-2.03%
Total Shareholder Return	5.42%	5.83%	3.19%	1.32%	-6.91%	0.18%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.